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Usefulness of Quantitative Endotracheal Aspirate Cultures in 
Intensive Care Unit Patients with Suspected Pneumonia
It is difficult to differentiate pathogens responsible for pneumonia or colonization in 
patients with an endotracheal tube or in patients that have undergone tracheostomy. We 
evaluated the clinical usefulness of quantitative endotracheal aspirates cultures and sought 
to determine the result threshold level for positivity. The authors performed this 
retrospective cohort study between December 1, 2004 and January 31, 2006. Forty-five 
suspected pneumonia patients admitted to an intensive care unit (ICU) with quantitative 
bronchoalveolar lavage (BAL) and endotracheal aspirate (EA) culture results were enrolled. 
Using a threshold of 10
5 cfu/mL, 10 of the 45 (22.2%) quantitative EA cultures were 
positive, as compared with 7 (15.6%) BAL cultures. When BAL culture findings were used 
as the reference, the sensitivity and specificity of quantitative EA cultures were 85.7% and 
89.5%, respectively, at a threshold of 10
5 cfu/mL, and 85.7% and 94.7%, respectively, at 
a threshold of 10
6 cfu/mL. Of the 10 EA culture positive patients, 2 patients with a result of 
-10
5 cfu/mL were BAL culture negative. The quantitative EA culture is a useful non-invasive 
tool for the diagnosis of pneumonia pathogens. It is suggested that a threshold level of 10
6 
cfu/mL is appropriate.
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INTRODUCTION
The accurate diagnosis of newly developed pneumonia is diffi-
cult in patients with an endotracheal tube or tracheostomy (1), 
since many other conditions, such as, tracheobronchitis (2), pul-
monary edema, and atelectasis, can mimic pneumonia. There-
fore bacteriologic tests are necessary to confirm pneumonia; 
Infectious Diseases Society of America/American Thoracic So-
ciety (IDSA/ATS) guideline is that samples of lower respiratory 
tract secretions should be obtained from all patients with sus-
pected hospital acquired pneumonia (HAP) which should be 
collected before antibiotic changes. Samples can include an en-
dotracheal aspirate, bronchoalveolar lavage sample, or protect-
ed specimen brush sample (2). 
  But qualitative endotracheal aspirate (EA) culture cannot dif-
ferentiate colonization from infection (3, 4). Although quantita-
tive culture of bronchoalveolar lavage (BAL) fluid obtained by 
bronchoscopy can accurately diagnose pneumonia, this proce-
dure is invasive and cannot be utilized in some patients, espe-
cially in those who are critical (5-12). 
  Quantitative EA culture is non-invasive, easily learnt, and 
cheaper than quantitative BAL fluid culture (4, 13); and previ-
ous results have suggested that EA can be used as a substitute 
for BAL in quantitative cultures (4). However, this issue is con-
troversial and result thresholds have not been determined. Fur-
thermore, little data is available on quantitative EA cultures in 
Korea, or on the clinical applications of this methodology. Ac-
cordingly, we evaluated the clinical usefulness of quantitative 
EA cultures in intensive care unit (ICU) patients with pneumo-
nia, and sought to determine the result threshold level for posi-
tivity.
 
MATERIALS AND METHODS
We performed this retrospective cohort study between Decem-
ber 1, 2004 and January 31, 2006. Patients with an endotracheal 
tube or tracheostomy suspected of having pneumonia admitted 
to medical ICU at the Asan Medical Center were enrolled whose 
EA sample was collected within 2 days of a BAL sample. Patients 
with community acquired, hospital acquired, and health care 
associated pneumonia were included, as were immunocom-
promised or immunocompetent patients, who had previously 
received antibiotics. However, patients a with lower clinical pul-
monary infection score (CPIS) of < 6 or with an interval between Shin YM, et al.  •  Quantitative Culture of Endotracheal Aspirates
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BAL fluid and EA sampling of > 48 hr were excluded. 
  We evaluated patient demographic data, hospital courses, 
microbiologic results, the use of antibiotics, and radiographic 
changes. Acute physiology and chronic health evaluation 
(APACHE) II scores were determined at ICU admission, and 
CPIS scores on the first and third days after the onset of hospital 
acquired pneumonia. 
  EA samples with > 10 epithelial cells per low power field on a 
Gram stained slide of a direct smear were rejected as inadequate 
for culture. EA cultures were quantified using calibrated loops. 
Briefly, each 1 microliter of EA itself and 100-fold diluted EA were 
evenly streaked with 1 microliter-disposable plastic loop on en-
tire surface of a chocolate agar plate, a sheep blood agar plate, 
and a MacConkey agar plate. Plates are incubated overnight in 
a 5% CO2 atmosphere at 35°C. Colonies were then counted and 
bacterial concentrations (cfu/mL) were calculated. Microorgan-
isms with counts > 10
4 cfu/mL were submitted for identification 
and antimicrobial susceptibility testing. If no growth was detect-
ed on any plate, the incubation was extended for 24 hr. 
  Statistical analysis was performed using SPSS version 10.0 
(SPSS, Chicago, IL, USA). Results are expressed as means ± SDs. 
The chi-square test was used to compare proportions. Threshold 
levels of 10
5, 10
6, and 10
7 cfu/mL were used to evaluate quanti-
tative EA culture positivity, but quantitative BAL culture positiv-
ity was defined as 10
4 cfu/mL, which is an established threshold 
level. Sensitivity, specificity, and the predictive values of quan-
titative EA cultures were calculated at each of the three thresh-
old levels. Kappa analysis was used to determine concordance 
rates between quantitative EA and BAL culture results.
Ethics statement 
This study protocol was approved by the institutional review 
board (IRB) of Asan Medical Center (Approval number: 2011-
0170). This study was exempted from written informed consent 
and all the data collected from this study was kept confidential.
RESULTS
A total of 45 patients (32 men, 13 women, mean age 63.4 ± 13.2 
yr) were enrolled. Patient demographic data is provided in Table 
1. Twenty-eight patients had hospital acquired pneumonia and 
17 had community acquired pneumonia (CAP). Their underly-
ing diseases included malignancy, chronic lung disease, rheu-
matologic disease, and others. The majority of patients (n = 36) 
were immunocompromised, and 17 of these had previously re-
ceived chemotherapeutic agents, corticosteroids, or immuno-
suppressive agents. The major cause of ICU admission was re-
spiratory failure and hypoxemia. Total patients’ mean APACHE 
II score at ICU admission was 29.4 ± 7.3. In patients with hospi-
tal acquired pneumonia, mean CPIS scores on days 1 and 3 af-
ter pneumonia onset were 8.7 ± 2.0 and 8.5 ± 2.0, respectively. 
  Table 2 shows the hospital courses of the patients. Mean length 
of ICU stay was 29.8 ± 26.8 days and mean duration of mechan-
ical ventilation was 26.4 ± 25.3 days. The average time between 
BAL and EA sampling was 0.2 ± 0.9 days. Using a threshold of 
10
5 cfu/mL, 10 (22.2%) quantitative EA cultures were positive, 
as compared with 7 (15.6%) BAL cultures (Table 3). Six of the 7 
patients with a positive BAL cultures had a positive EA culture. 
Of the 10 EA culture (+) patients, 2 patients with 10
5 cfu/mL had 
all BAL culture (-), and of the 8 EA culture (+) patients (at a thresh-
Table 1. Patient demographics and clinical characteristics at baseline
Clinical characteristics Data
Total number 45
Age (yr) 63.4 ± 13.2
Sex (M/F) 32/13
Pneumonia
   HAP
   CAP
 
28
17
Underlying disease
   Malignancy
   Chronic lung disease
   Transplantation recipient
   Rheumatologic disease
   Gastrointestinal disease
   History of malignancy
   Stroke
   Other
 
19
  8
  2
  4
  4
  3
  3
  2
Immune status
   Immuno-competent
   Immuno-compromised
 
  9
36
Previous medication
   Steroid
   Chemotherapeutic agent
   Immunosuppressant
   None
 
  5
  8
  4
28
Previous antibiotics
   Yes
   No
 
29
16
Cause of ICU care
   Respiratory failure and hypoxemia
   Shock
   Close monitoring
   Post-operation
 
36
  3
  4
  2
HAP, hospital acquired pneumonia; CAP, community acquired pneumonia.
Table 2. Patient characteristics at ICU admission, clinical pulmonary infection score 
(CPIS) on days 1 and 3 after pneumonia onset in patients with hospital acquired pneu-
monia and hospital courses (days)
Parameters Mean ± SD
APACHE II score on ICU admission 29.4 ± 7.3
CPIS (n = 28)
   Day 1
   Day 3
 
  8.7 ± 2.0
  8.5 ± 2.0
Hospital days
   Duration of ICU stay
   Duration of mechanical ventilation
 
  29.8 ± 26.8
  26.4 ± 25.3
Duration of mechanical ventilation before BAL (total)
   In HAP
   In CAP
    8.1 ± 14.0
  11.8 ± 17.0
  2.2 ± 2.3
Time between BAL and EA   0.2 ± 0.9
SD, standard deviation.Shin YM, et al.  •  Quantitative Culture of Endotracheal Aspirates
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old of 10
6 cfu/mL), 6 were BAL culture (+).
  We calculated the diagnostic efficiencies of quantitative EA 
culture at each threshold level. When BAL culture findings were 
used as reference, the sensitivity and specificity of quantitative 
EA culture at a threshold of 10
5 cfu/mL were 85.7% and 89.5%, 
respectively and at a threshold of 10
6 cfu/mL, these were 85.7% 
and 94.7%, respectively (Table 4). Kappa analysis showed that 
the concordance rate of the two diagnostic methods was best at 
a quantitative EA culture threshold of 10
6 cfu/mL. The area un-
der the ROC curve of quantitative EA culture at this threshold 
was 0.902 (Fig. 1). 
  After obtaining culture results, antibiotic regimens were al-
tered in 19 (42%) of the 45 patients. In 16 (36%) patients, antibi-
otics were deescalated and these included 12 patients on van-
comycin because of a lack of evidence of methicillin-resistant 
Staphylococcus aureus infection. When we evaluated positivity 
rates with respect to time of antibiotic use before BAL, we ob-
served higher positivity rate in patients who had received anti-
biotics for 7 days or longer (P = 0.017). 
DISCUSSION
This study shows that quantitative endotracheal aspirate culture 
is a useful non-invasive tool for the diagnosis of pneumonia 
pathogens in critically ill patients. Our findings suggest that a 
threshold level of 10
6 cfu/mL is appropriate because at this level 
excellent concordance was found with quantitative BAL culture 
results. 
  Ventilator associated pneumonia (VAP) or severe CAP is diffi-
cult to diagnosis in ICU patients with an endotracheal tube or a 
tracheostomy. It is associated with high mortality and morbidity 
rates (14). Thus, early and accurate diagnosis and appropriate 
empirical antibiotic treatment are important outcome variables 
(14). 
  Many clinical conditions mimic pneumonia in these patients, 
which in practice, means that microbiologic evaluations are re-
quired for the diagnosis of pneumonia. However, it is difficult to 
obtain specimens from the lower respiratory tract without con-
tamination by colonizing bacteria. Therefore culture results are 
invariably often difficult to interpret. Since qualitative cultures 
are unable to distinguish between pathogens and colonizing bac-
teria, the concept of quantitative culture was developed based 
Table 4. Characteristics of quantitative EA cultures and the concordance between quantitative BAL and EA cultures
Threshold Sensitivity (%) Specificity (%)   PPV (%) NPV (%) κ  P value Concordance 
≥ 10
5 85.7      89.5      60.0 97.1 0.64 0.00 Good 
≥ 10
6 85.7      94.7      75.0 97.3 0.76 0.00 Excellent 
≥ 10
7 14.3 100 100 86.4 0.22   0.018 Poor 
PPV, positive predictive value; NPV, negative predictive value.
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Fig. 1. ROC curve of quantitative EA culture.
Table 3. Microbiologic results of quantitative cultures, previous antibiotics duration (days) before BAL and type of pneumonia in patients with positive culture
Patient number EA    Q*  BAL Q Previous antibiotics 
duration (days)
Type of  
pneumonia
  1 MRSA    3 × 10
5 0 0    7 HAP
  8 MRSA 1.5 × 10
6 MRSA    4 × 10
5 > 7 HAP
  9 IRPA 2.5 × 10
6 IRPA    1 × 10
7    0 HAP
10 S. maltophilia    5 × 10
6 0 0 > 7 HAP
12 IRPA    1 × 10
6 IRPA    1 × 10
6 > 7 HAP
16 A. baumanii    5 × 10
7 A. baumanii 1.4 × 10
6 > 7 HAP
24 ESBL    2 × 10
6 ESBL    5 × 10
4 > 7 HAP
28 P. aeruginosa    6 × 10
5 0 0    5 CAP
31 S. maltophilia    2 × 10
6 S. maltophilia    1 × 10
6 > 7 HAP
36 0 0 MRSA    5 × 10
5 > 7 HAP
43 S. maltophilia    5 × 10
6 S. maltophilia    4 × 10
3 > 7 HAP
*Culture counts. MRSA, methicillin resistant Staphylococcus aureus; IRPA, imipenem resistant Pseudomonas aeruginosa; ESBL, extended-spectrum β-lactamases. Shin YM, et al.  •  Quantitative Culture of Endotracheal Aspirates
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on BAL, protected specimen brush (PSB), blinded protected 
telescoping catheter, and EA cultures (15-21). 
  Quantitative EA cultures are straightforward, cheap, easily per-
formed, and non-invasive and have been shown to be useful in 
Western countries (22-26). Previous studies included compara-
tive evaluations of the accuracy of quantitative EA cultures for 
the diagnosis of VAP versus other diagnostic methods, such as, 
autopsy specimen, BAL, or PSB culture, or clinical methods (22, 
24-28). In general, each of these methods is of clinical value, pri-
marily because of the invasive nature of bronchoscopy (5-12), 
but their sensitivities and specificities vary. Additionally positiv-
ity thresholds are controversial, 10
5 cfu/mL (22, 26, 29), or 10
6 
cfu/mL (24, 25, 27).
  No reference autopsy specimen was available for this study. 
Therefore we used quantitative BAL cultures and clinical diag-
nosis as diagnostic standards to confirm the presence of pneu-
monia. 
  When we compared the sensitivity, specificity, and concor-
dance of quantitative EA and quantitative BAL culture, we found 
that the optimal quantitative EA culture threshold level was 10
6 
cfu/mL. 
  Furthermore, in patients with hospital acquired pneumonia, 
we also used CPIS (30). No patient with HAP had a CPIS score 
of < 6 on day 1 and 3 after pneumonia onset, so this study showed 
high specificity (94.7%) than previous studies that did not use it 
(24, 25, 27).
  When 10
4 cfu/mL was used as a cutoff value for quantitative 
BAL cultures, we found that 15.6% of BAL cultures were positive, 
which is lower than previous studies. This may have been low 
because we do not routinely perform quantitative BAL culture 
in critically ill patients with suspected pneumonia. We performed 
quantitative BAL culture in ICU patients with a poor clinical re-
sponse to a previous empirical regimen or atypical clinical symp-
toms or signs. So we might enrolled many difficult patients to 
diagnose or patients suspected of having an atypical pathogens. 
Furthermore, many of the cultured bacteria were drug resistant 
organisms. These may be partially explained by culture positiv-
ity rate was high in patients with prolonged antibiotic use rather 
than short term antibiotic use. Only one CAP patient showed 
positive EA culture and the others were HAP patients. We had 
more HAP patients (HAP 28/CAP 17 patients) and most of CAP 
patients received antibiotics initiation before BAL. When we in-
cluded in patients with HAP only, EA and BAL culture rates were 
32.1% and 25% respectively.
  In our cohort, the antibiotic regimen was changed in 19 pa-
tients, including 12 maintained on antibiotics after vancomycin 
discontinuance, and these actions were taken based on our quan-
titative culture results. Thus, quantitative EA culture is likely to 
reduce antibiotic use.
  Several study limitations should be borne in mind. First, this 
was not a randomized controlled study. Besides BAL was not 
performed routinely in all patients with pneumonia or in pa-
tients that responded well to antibiotics due to its invasiveness. 
Accordingly, this study was performed in patients who had con-
tracted a difficult pathogen to diagnose. In addition, we also in-
cluded many patients who had been previously treated with an-
tibiotics, and we enrolled community and hospital acquired 
pneumonia cases.
  Summarizing, quantitative EA cultures are useful non-inva-
sive diagnostic tool in critically ill patients with an endotracheal 
tube or tracheostomy suspected of having pneumonia especial-
ly in HAP. It is also suggested that the appropriate threshold lev-
el for quantitative EA culture is 10
6 cfu/mL. 
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